Pemoline

匹莫林

Report date: 2026/02/06 17:14:08
NME

Base Information

Drug NamePemoline
Drug Alias Namepemolina佩默林Pemolinum匹吗啉Phenoxazole +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors modulators
TargetsDopamine receptors
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityCocaine-Related Disorders
Global Approved IndicationsAttention Deficit Disorder with Hyperactivity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1975/01/27
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesYale UniversityNational Institute On Drug Abuse
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityCocaine-Related Disorders

Other Information

ATC CodeN06BA05
Related LinksWikipediaDrugBankKEGG